nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2C8—Mometasone—atopic dermatitis	0.0836	0.136	CbGbCtD
Morphine—CYP2C8—Loratadine—atopic dermatitis	0.048	0.0784	CbGbCtD
Morphine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0447	0.073	CbGbCtD
Morphine—ABCB1—Tacrolimus—atopic dermatitis	0.0444	0.0725	CbGbCtD
Morphine—ABCB1—Loratadine—atopic dermatitis	0.0325	0.0531	CbGbCtD
Morphine—CYP2D6—Loratadine—atopic dermatitis	0.0306	0.05	CbGbCtD
Morphine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0306	0.05	CbGbCtD
Morphine—ABCB1—Methylprednisolone—atopic dermatitis	0.0297	0.0485	CbGbCtD
Morphine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0267	0.0436	CbGbCtD
Morphine—CYP3A4—Tacrolimus—atopic dermatitis	0.0266	0.0434	CbGbCtD
Morphine—CYP3A4—Loratadine—atopic dermatitis	0.0195	0.0318	CbGbCtD
Morphine—ABCB1—Betamethasone—atopic dermatitis	0.0193	0.0316	CbGbCtD
Morphine—ABCB1—Prednisolone—atopic dermatitis	0.0191	0.0311	CbGbCtD
Morphine—ABCB1—Hydrocortisone—atopic dermatitis	0.0181	0.0295	CbGbCtD
Morphine—ABCB1—Prednisone—atopic dermatitis	0.018	0.0294	CbGbCtD
Morphine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0178	0.0291	CbGbCtD
Morphine—CYP2C8—Dexamethasone—atopic dermatitis	0.0166	0.0271	CbGbCtD
Morphine—CYP3A4—Triamcinolone—atopic dermatitis	0.0135	0.022	CbGbCtD
Morphine—CYP3A4—Betamethasone—atopic dermatitis	0.0116	0.0189	CbGbCtD
Morphine—CYP3A4—Prednisolone—atopic dermatitis	0.0114	0.0187	CbGbCtD
Morphine—ABCB1—Dexamethasone—atopic dermatitis	0.0112	0.0184	CbGbCtD
Morphine—CYP3A4—Hydrocortisone—atopic dermatitis	0.0108	0.0177	CbGbCtD
Morphine—CYP3A4—Prednisone—atopic dermatitis	0.0108	0.0176	CbGbCtD
Morphine—CYP2D6—Dexamethasone—atopic dermatitis	0.0106	0.0173	CbGbCtD
Morphine—CYP3A4—Dexamethasone—atopic dermatitis	0.00673	0.011	CbGbCtD
Morphine—OPRL1—Signaling Pathways—STAT6—atopic dermatitis	0.000127	0.00144	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—IL6—atopic dermatitis	0.000127	0.00143	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000126	0.00143	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	0.000126	0.00142	CbGpPWpGaD
Morphine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000125	0.000418	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000125	0.00141	CbGpPWpGaD
Morphine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000125	0.000417	CcSEcCtD
Morphine—Rash—Tacrolimus—atopic dermatitis	0.000125	0.000416	CcSEcCtD
Morphine—Dermatitis—Tacrolimus—atopic dermatitis	0.000124	0.000416	CcSEcCtD
Morphine—Shock—Prednisolone—atopic dermatitis	0.000124	0.000415	CcSEcCtD
Morphine—Cough—Triamcinolone—atopic dermatitis	0.000124	0.000415	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000124	0.0014	CbGpPWpGaD
Morphine—Headache—Tacrolimus—atopic dermatitis	0.000124	0.000414	CcSEcCtD
Morphine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000123	0.00139	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000123	0.00139	CbGpPWpGaD
Morphine—Oedema—Hydrocortisone—atopic dermatitis	0.000123	0.000412	CcSEcCtD
Morphine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000123	0.000412	CcSEcCtD
Morphine—Convulsion—Triamcinolone—atopic dermatitis	0.000123	0.000412	CcSEcCtD
Morphine—Tachycardia—Prednisolone—atopic dermatitis	0.000123	0.000412	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000123	0.00139	CbGpPWpGaD
Morphine—Convulsion—Methylprednisolone—atopic dermatitis	0.000123	0.000411	CcSEcCtD
Morphine—Hypertension—Triamcinolone—atopic dermatitis	0.000123	0.00041	CcSEcCtD
Morphine—Hypertension—Methylprednisolone—atopic dermatitis	0.000122	0.00041	CcSEcCtD
Morphine—Infection—Hydrocortisone—atopic dermatitis	0.000122	0.000409	CcSEcCtD
Morphine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000122	0.000408	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000121	0.00137	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000121	0.00137	CbGpPWpGaD
Morphine—Shock—Hydrocortisone—atopic dermatitis	0.000121	0.000405	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000121	0.00137	CbGpPWpGaD
Morphine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000121	0.000404	CcSEcCtD
Morphine—Arthralgia—Methylprednisolone—atopic dermatitis	0.000121	0.000404	CcSEcCtD
Morphine—Eye disorder—Prednisone—atopic dermatitis	0.000121	0.000403	CcSEcCtD
Morphine—OPRL1—GPCR ligand binding—CXCL8—atopic dermatitis	0.00012	0.00136	CbGpPWpGaD
Morphine—Anxiety—Methylprednisolone—atopic dermatitis	0.00012	0.000402	CcSEcCtD
Morphine—Tachycardia—Hydrocortisone—atopic dermatitis	0.00012	0.000402	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00012	0.000401	CcSEcCtD
Morphine—Flushing—Prednisone—atopic dermatitis	0.00012	0.000401	CcSEcCtD
Morphine—Skin disorder—Hydrocortisone—atopic dermatitis	0.00012	0.0004	CcSEcCtD
Morphine—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00012	0.0004	CcSEcCtD
Morphine—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00012	0.0004	CcSEcCtD
Morphine—Discomfort—Triamcinolone—atopic dermatitis	0.00012	0.0004	CcSEcCtD
Morphine—Discomfort—Methylprednisolone—atopic dermatitis	0.000119	0.000399	CcSEcCtD
Morphine—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000119	0.00135	CbGpPWpGaD
Morphine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000119	0.000398	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000119	0.00134	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000118	0.00134	CbGpPWpGaD
Morphine—Dry mouth—Triamcinolone—atopic dermatitis	0.000118	0.000396	CcSEcCtD
Morphine—Anorexia—Hydrocortisone—atopic dermatitis	0.000117	0.000393	CcSEcCtD
Morphine—Nausea—Tacrolimus—atopic dermatitis	0.000117	0.000392	CcSEcCtD
Morphine—Angiopathy—Prednisone—atopic dermatitis	0.000117	0.000392	CcSEcCtD
Morphine—Confusional state—Methylprednisolone—atopic dermatitis	0.000117	0.00039	CcSEcCtD
Morphine—Malaise—Dexamethasone—atopic dermatitis	0.000116	0.000389	CcSEcCtD
Morphine—Malaise—Betamethasone—atopic dermatitis	0.000116	0.000389	CcSEcCtD
Morphine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000116	0.000388	CcSEcCtD
Morphine—Oedema—Triamcinolone—atopic dermatitis	0.000116	0.000388	CcSEcCtD
Morphine—Vertigo—Betamethasone—atopic dermatitis	0.000116	0.000388	CcSEcCtD
Morphine—Vertigo—Dexamethasone—atopic dermatitis	0.000116	0.000388	CcSEcCtD
Morphine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000116	0.000387	CcSEcCtD
Morphine—Syncope—Dexamethasone—atopic dermatitis	0.000116	0.000387	CcSEcCtD
Morphine—Syncope—Betamethasone—atopic dermatitis	0.000116	0.000387	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000116	0.0013	CbGpPWpGaD
Morphine—Infection—Triamcinolone—atopic dermatitis	0.000115	0.000385	CcSEcCtD
Morphine—Hypotension—Hydrocortisone—atopic dermatitis	0.000115	0.000385	CcSEcCtD
Morphine—Infection—Methylprednisolone—atopic dermatitis	0.000115	0.000385	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000115	0.0013	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000114	0.00129	CbGpPWpGaD
Morphine—Shock—Triamcinolone—atopic dermatitis	0.000114	0.000382	CcSEcCtD
Morphine—Insomnia—Prednisolone—atopic dermatitis	0.000114	0.000382	CcSEcCtD
Morphine—Shock—Methylprednisolone—atopic dermatitis	0.000114	0.000381	CcSEcCtD
Morphine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000114	0.00038	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—CCL5—atopic dermatitis	0.000113	0.00128	CbGpPWpGaD
Morphine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000113	0.000379	CcSEcCtD
Morphine—Loss of consciousness—Betamethasone—atopic dermatitis	0.000113	0.000379	CcSEcCtD
Morphine—Paraesthesia—Prednisolone—atopic dermatitis	0.000113	0.000379	CcSEcCtD
Morphine—Tachycardia—Triamcinolone—atopic dermatitis	0.000113	0.000379	CcSEcCtD
Morphine—Mental disorder—Prednisone—atopic dermatitis	0.000113	0.000378	CcSEcCtD
Morphine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000113	0.000378	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000113	0.00127	CbGpPWpGaD
Morphine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000112	0.000376	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000112	0.00127	CbGpPWpGaD
Morphine—Erythema—Prednisone—atopic dermatitis	0.000112	0.000376	CcSEcCtD
Morphine—Malnutrition—Prednisone—atopic dermatitis	0.000112	0.000376	CcSEcCtD
Morphine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000112	0.000375	CcSEcCtD
Morphine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000112	0.000375	CcSEcCtD
Morphine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000112	0.000374	CcSEcCtD
Morphine—Convulsion—Betamethasone—atopic dermatitis	0.000112	0.000374	CcSEcCtD
Morphine—Convulsion—Dexamethasone—atopic dermatitis	0.000112	0.000374	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000112	0.00126	CbGpPWpGaD
Morphine—Insomnia—Hydrocortisone—atopic dermatitis	0.000111	0.000373	CcSEcCtD
Morphine—Hypertension—Dexamethasone—atopic dermatitis	0.000111	0.000372	CcSEcCtD
Morphine—Hypertension—Betamethasone—atopic dermatitis	0.000111	0.000372	CcSEcCtD
Morphine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000111	0.00037	CcSEcCtD
Morphine—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00011	0.00125	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCR3—atopic dermatitis	0.00011	0.00124	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00011	0.00124	CbGpPWpGaD
Morphine—Anxiety—Betamethasone—atopic dermatitis	0.000109	0.000366	CcSEcCtD
Morphine—Anxiety—Dexamethasone—atopic dermatitis	0.000109	0.000366	CcSEcCtD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000109	0.00123	CbGpPWpGaD
Morphine—Discomfort—Dexamethasone—atopic dermatitis	0.000109	0.000363	CcSEcCtD
Morphine—Discomfort—Betamethasone—atopic dermatitis	0.000109	0.000363	CcSEcCtD
Morphine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000108	0.000363	CcSEcCtD
Morphine—Hypotension—Methylprednisolone—atopic dermatitis	0.000108	0.000362	CcSEcCtD
Morphine—Pain—Prednisolone—atopic dermatitis	0.000108	0.000361	CcSEcCtD
Morphine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000107	0.000358	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000107	0.00121	CbGpPWpGaD
Morphine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000106	0.000356	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000106	0.0012	CbGpPWpGaD
Morphine—Fatigue—Hydrocortisone—atopic dermatitis	0.000106	0.000355	CcSEcCtD
Morphine—Vision blurred—Prednisone—atopic dermatitis	0.000106	0.000354	CcSEcCtD
Morphine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000106	0.000354	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000105	0.000353	CcSEcCtD
Morphine—Pain—Hydrocortisone—atopic dermatitis	0.000105	0.000352	CcSEcCtD
Morphine—Oedema—Dexamethasone—atopic dermatitis	0.000105	0.000352	CcSEcCtD
Morphine—Oedema—Betamethasone—atopic dermatitis	0.000105	0.000352	CcSEcCtD
Morphine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000105	0.000352	CcSEcCtD
Morphine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000105	0.000352	CcSEcCtD
Morphine—Insomnia—Triamcinolone—atopic dermatitis	0.000105	0.000351	CcSEcCtD
Morphine—Insomnia—Methylprednisolone—atopic dermatitis	0.000105	0.00035	CcSEcCtD
Morphine—Infection—Dexamethasone—atopic dermatitis	0.000105	0.00035	CcSEcCtD
Morphine—Infection—Betamethasone—atopic dermatitis	0.000105	0.00035	CcSEcCtD
Morphine—Ill-defined disorder—Prednisone—atopic dermatitis	0.000104	0.000349	CcSEcCtD
Morphine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000104	0.000348	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000104	0.00118	CbGpPWpGaD
Morphine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000104	0.000348	CcSEcCtD
Morphine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000104	0.000348	CcSEcCtD
Morphine—Anaemia—Prednisone—atopic dermatitis	0.000104	0.000347	CcSEcCtD
Morphine—Shock—Dexamethasone—atopic dermatitis	0.000104	0.000346	CcSEcCtD
Morphine—Shock—Betamethasone—atopic dermatitis	0.000104	0.000346	CcSEcCtD
Morphine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000103	0.000346	CcSEcCtD
Morphine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000103	0.000345	CcSEcCtD
Morphine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000103	0.000345	CcSEcCtD
Morphine—Agitation—Prednisone—atopic dermatitis	0.000103	0.000345	CcSEcCtD
Morphine—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000103	0.000345	CcSEcCtD
Morphine—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000103	0.000345	CcSEcCtD
Morphine—Tachycardia—Dexamethasone—atopic dermatitis	0.000103	0.000344	CcSEcCtD
Morphine—Tachycardia—Betamethasone—atopic dermatitis	0.000103	0.000344	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000103	0.00116	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000103	0.00116	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CCR5—atopic dermatitis	0.000102	0.00115	CbGpPWpGaD
Morphine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000102	0.000342	CcSEcCtD
Morphine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000102	0.000341	CcSEcCtD
Morphine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000102	0.00034	CcSEcCtD
Morphine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000102	0.00034	CcSEcCtD
Morphine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000102	0.00034	CcSEcCtD
Morphine—Malaise—Prednisone—atopic dermatitis	0.000101	0.000339	CcSEcCtD
Morphine—Vertigo—Prednisone—atopic dermatitis	0.000101	0.000338	CcSEcCtD
Morphine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000101	0.000337	CcSEcCtD
Morphine—Syncope—Prednisone—atopic dermatitis	0.000101	0.000337	CcSEcCtD
Morphine—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000101	0.00114	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000101	0.00114	CbGpPWpGaD
Morphine—Anorexia—Dexamethasone—atopic dermatitis	0.0001	0.000336	CcSEcCtD
Morphine—Anorexia—Betamethasone—atopic dermatitis	0.0001	0.000336	CcSEcCtD
Morphine—Urticaria—Prednisolone—atopic dermatitis	0.0001	0.000335	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.0001	0.00113	CbGpPWpGaD
Morphine—Fatigue—Triamcinolone—atopic dermatitis	0.0001	0.000335	CcSEcCtD
Morphine—UGT1A3—Metabolism—GLB1—atopic dermatitis	9.99e-05	0.00113	CbGpPWpGaD
Morphine—Fatigue—Methylprednisolone—atopic dermatitis	9.98e-05	0.000334	CcSEcCtD
Morphine—Pain—Triamcinolone—atopic dermatitis	9.92e-05	0.000332	CcSEcCtD
Morphine—Loss of consciousness—Prednisone—atopic dermatitis	9.87e-05	0.00033	CcSEcCtD
Morphine—Hypotension—Dexamethasone—atopic dermatitis	9.84e-05	0.000329	CcSEcCtD
Morphine—Hypotension—Betamethasone—atopic dermatitis	9.84e-05	0.000329	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—TAC1—atopic dermatitis	9.82e-05	0.00111	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NPS—atopic dermatitis	9.82e-05	0.00111	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.79e-05	0.00111	CbGpPWpGaD
Morphine—Urticaria—Hydrocortisone—atopic dermatitis	9.79e-05	0.000327	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	9.77e-05	0.0011	CbGpPWpGaD
Morphine—Abdominal pain—Hydrocortisone—atopic dermatitis	9.74e-05	0.000326	CcSEcCtD
Morphine—Body temperature increased—Hydrocortisone—atopic dermatitis	9.74e-05	0.000326	CcSEcCtD
Morphine—Convulsion—Prednisone—atopic dermatitis	9.73e-05	0.000325	CcSEcCtD
Morphine—Hypertension—Prednisone—atopic dermatitis	9.7e-05	0.000324	CcSEcCtD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	9.66e-05	0.00109	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCR3—atopic dermatitis	9.63e-05	0.00109	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	9.63e-05	0.00109	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	9.61e-05	0.00109	CbGpPWpGaD
Morphine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.59e-05	0.000321	CcSEcCtD
Morphine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.59e-05	0.000321	CcSEcCtD
Morphine—UGT1A3—Metabolism—ADSL—atopic dermatitis	9.58e-05	0.00108	CbGpPWpGaD
Morphine—Arthralgia—Prednisone—atopic dermatitis	9.56e-05	0.00032	CcSEcCtD
Morphine—Feeling abnormal—Triamcinolone—atopic dermatitis	9.56e-05	0.00032	CcSEcCtD
Morphine—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.54e-05	0.000319	CcSEcCtD
Morphine—Anxiety—Prednisone—atopic dermatitis	9.53e-05	0.000319	CcSEcCtD
Morphine—Insomnia—Dexamethasone—atopic dermatitis	9.52e-05	0.000318	CcSEcCtD
Morphine—Insomnia—Betamethasone—atopic dermatitis	9.52e-05	0.000318	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	9.5e-05	0.000318	CcSEcCtD
Morphine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.47e-05	0.000317	CcSEcCtD
Morphine—Paraesthesia—Dexamethasone—atopic dermatitis	9.45e-05	0.000316	CcSEcCtD
Morphine—Paraesthesia—Betamethasone—atopic dermatitis	9.45e-05	0.000316	CcSEcCtD
Morphine—Discomfort—Prednisone—atopic dermatitis	9.45e-05	0.000316	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	9.44e-05	0.00107	CbGpPWpGaD
Morphine—Hypersensitivity—Prednisolone—atopic dermatitis	9.3e-05	0.000311	CcSEcCtD
Morphine—Dyspepsia—Dexamethasone—atopic dermatitis	9.27e-05	0.00031	CcSEcCtD
Morphine—Dyspepsia—Betamethasone—atopic dermatitis	9.27e-05	0.00031	CcSEcCtD
Morphine—Urticaria—Triamcinolone—atopic dermatitis	9.22e-05	0.000308	CcSEcCtD
Morphine—Urticaria—Methylprednisolone—atopic dermatitis	9.2e-05	0.000308	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	9.19e-05	0.00104	CbGpPWpGaD
Morphine—Body temperature increased—Triamcinolone—atopic dermatitis	9.17e-05	0.000307	CcSEcCtD
Morphine—Oedema—Prednisone—atopic dermatitis	9.17e-05	0.000307	CcSEcCtD
Morphine—Anaphylactic shock—Prednisone—atopic dermatitis	9.17e-05	0.000307	CcSEcCtD
Morphine—Abdominal pain—Methylprednisolone—atopic dermatitis	9.15e-05	0.000306	CcSEcCtD
Morphine—Decreased appetite—Betamethasone—atopic dermatitis	9.15e-05	0.000306	CcSEcCtD
Morphine—Decreased appetite—Dexamethasone—atopic dermatitis	9.15e-05	0.000306	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—IL5—atopic dermatitis	9.13e-05	0.00103	CbGpPWpGaD
Morphine—Infection—Prednisone—atopic dermatitis	9.11e-05	0.000305	CcSEcCtD
Morphine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.09e-05	0.000304	CcSEcCtD
Morphine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.09e-05	0.000304	CcSEcCtD
Morphine—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.08e-05	0.000304	CcSEcCtD
Morphine—Fatigue—Betamethasone—atopic dermatitis	9.08e-05	0.000304	CcSEcCtD
Morphine—Fatigue—Dexamethasone—atopic dermatitis	9.08e-05	0.000304	CcSEcCtD
Morphine—Shock—Prednisone—atopic dermatitis	9.02e-05	0.000302	CcSEcCtD
Morphine—Pain—Betamethasone—atopic dermatitis	9e-05	0.000301	CcSEcCtD
Morphine—Pain—Dexamethasone—atopic dermatitis	9e-05	0.000301	CcSEcCtD
Morphine—Nervous system disorder—Prednisone—atopic dermatitis	8.99e-05	0.000301	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	8.98e-05	0.00101	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	8.96e-05	0.00101	CbGpPWpGaD
Morphine—Tachycardia—Prednisone—atopic dermatitis	8.95e-05	0.000299	CcSEcCtD
Morphine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	8.93e-05	0.00101	CbGpPWpGaD
Morphine—Skin disorder—Prednisone—atopic dermatitis	8.91e-05	0.000298	CcSEcCtD
Morphine—Hyperhidrosis—Prednisone—atopic dermatitis	8.86e-05	0.000296	CcSEcCtD
Morphine—Asthenia—Hydrocortisone—atopic dermatitis	8.84e-05	0.000296	CcSEcCtD
Morphine—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	8.83e-05	0.000997	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	8.77e-05	0.000991	CbGpPWpGaD
Morphine—Anorexia—Prednisone—atopic dermatitis	8.74e-05	0.000292	CcSEcCtD
Morphine—Pruritus—Hydrocortisone—atopic dermatitis	8.72e-05	0.000292	CcSEcCtD
Morphine—Feeling abnormal—Dexamethasone—atopic dermatitis	8.68e-05	0.00029	CcSEcCtD
Morphine—Feeling abnormal—Betamethasone—atopic dermatitis	8.68e-05	0.00029	CcSEcCtD
Morphine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.61e-05	0.000288	CcSEcCtD
Morphine—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.61e-05	0.000288	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	8.57e-05	0.000968	CbGpPWpGaD
Morphine—Hypersensitivity—Triamcinolone—atopic dermatitis	8.55e-05	0.000286	CcSEcCtD
Morphine—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.53e-05	0.000285	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	8.5e-05	0.00096	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GLB1—atopic dermatitis	8.49e-05	0.000959	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.49e-05	0.000959	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	8.45e-05	0.000954	CbGpPWpGaD
Morphine—Diarrhoea—Hydrocortisone—atopic dermatitis	8.43e-05	0.000282	CcSEcCtD
Morphine—Urticaria—Betamethasone—atopic dermatitis	8.36e-05	0.00028	CcSEcCtD
Morphine—Urticaria—Dexamethasone—atopic dermatitis	8.36e-05	0.00028	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.35e-05	0.000279	CcSEcCtD
Morphine—Dizziness—Prednisolone—atopic dermatitis	8.34e-05	0.000279	CcSEcCtD
Morphine—Asthenia—Triamcinolone—atopic dermatitis	8.33e-05	0.000278	CcSEcCtD
Morphine—Body temperature increased—Dexamethasone—atopic dermatitis	8.32e-05	0.000278	CcSEcCtD
Morphine—Body temperature increased—Betamethasone—atopic dermatitis	8.32e-05	0.000278	CcSEcCtD
Morphine—Abdominal pain—Dexamethasone—atopic dermatitis	8.32e-05	0.000278	CcSEcCtD
Morphine—Abdominal pain—Betamethasone—atopic dermatitis	8.32e-05	0.000278	CcSEcCtD
Morphine—Asthenia—Methylprednisolone—atopic dermatitis	8.31e-05	0.000278	CcSEcCtD
Morphine—Insomnia—Prednisone—atopic dermatitis	8.29e-05	0.000277	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	8.28e-05	0.000935	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	8.28e-05	0.000935	CbGpPWpGaD
Morphine—Paraesthesia—Prednisone—atopic dermatitis	8.23e-05	0.000275	CcSEcCtD
Morphine—Pruritus—Triamcinolone—atopic dermatitis	8.21e-05	0.000275	CcSEcCtD
Morphine—Pruritus—Methylprednisolone—atopic dermatitis	8.19e-05	0.000274	CcSEcCtD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.16e-05	0.000922	CbGpPWpGaD
Morphine—Dizziness—Hydrocortisone—atopic dermatitis	8.15e-05	0.000272	CcSEcCtD
Morphine—UGT2B7—Metabolism—ADSL—atopic dermatitis	8.14e-05	0.00092	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	8.13e-05	0.000918	CbGpPWpGaD
Morphine—Dyspepsia—Prednisone—atopic dermatitis	8.07e-05	0.00027	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	7.98e-05	0.000902	CbGpPWpGaD
Morphine—Decreased appetite—Prednisone—atopic dermatitis	7.97e-05	0.000267	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	7.96e-05	0.0009	CbGpPWpGaD
Morphine—Rash—Prednisolone—atopic dermatitis	7.96e-05	0.000266	CcSEcCtD
Morphine—Dermatitis—Prednisolone—atopic dermatitis	7.95e-05	0.000266	CcSEcCtD
Morphine—Diarrhoea—Methylprednisolone—atopic dermatitis	7.92e-05	0.000265	CcSEcCtD
Morphine—Fatigue—Prednisone—atopic dermatitis	7.91e-05	0.000264	CcSEcCtD
Morphine—Headache—Prednisolone—atopic dermatitis	7.9e-05	0.000264	CcSEcCtD
Morphine—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	7.85e-05	0.000887	CbGpPWpGaD
Morphine—Constipation—Prednisone—atopic dermatitis	7.84e-05	0.000262	CcSEcCtD
Morphine—Vomiting—Hydrocortisone—atopic dermatitis	7.84e-05	0.000262	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	7.82e-05	0.000883	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	7.82e-05	0.000883	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL10—atopic dermatitis	7.79e-05	0.00088	CbGpPWpGaD
Morphine—Rash—Hydrocortisone—atopic dermatitis	7.77e-05	0.00026	CcSEcCtD
Morphine—Dermatitis—Hydrocortisone—atopic dermatitis	7.76e-05	0.00026	CcSEcCtD
Morphine—Headache—Hydrocortisone—atopic dermatitis	7.72e-05	0.000258	CcSEcCtD
Morphine—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	7.69e-05	0.000869	CbGpPWpGaD
Morphine—Dizziness—Triamcinolone—atopic dermatitis	7.67e-05	0.000257	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	7.67e-05	0.000866	CbGpPWpGaD
Morphine—Dizziness—Methylprednisolone—atopic dermatitis	7.66e-05	0.000256	CcSEcCtD
Morphine—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	7.62e-05	0.00086	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	7.59e-05	0.000858	CbGpPWpGaD
Morphine—Feeling abnormal—Prednisone—atopic dermatitis	7.56e-05	0.000253	CcSEcCtD
Morphine—Asthenia—Dexamethasone—atopic dermatitis	7.55e-05	0.000253	CcSEcCtD
Morphine—Asthenia—Betamethasone—atopic dermatitis	7.55e-05	0.000253	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—atopic dermatitis	7.5e-05	0.000251	CcSEcCtD
Morphine—Nausea—Prednisolone—atopic dermatitis	7.49e-05	0.000251	CcSEcCtD
Morphine—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	7.46e-05	0.000842	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	7.46e-05	0.000842	CbGpPWpGaD
Morphine—Pruritus—Dexamethasone—atopic dermatitis	7.45e-05	0.000249	CcSEcCtD
Morphine—Pruritus—Betamethasone—atopic dermatitis	7.45e-05	0.000249	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	7.45e-05	0.000841	CbGpPWpGaD
Morphine—Vomiting—Triamcinolone—atopic dermatitis	7.38e-05	0.000247	CcSEcCtD
Morphine—Vomiting—Methylprednisolone—atopic dermatitis	7.36e-05	0.000246	CcSEcCtD
Morphine—Nausea—Hydrocortisone—atopic dermatitis	7.32e-05	0.000245	CcSEcCtD
Morphine—Rash—Triamcinolone—atopic dermatitis	7.32e-05	0.000245	CcSEcCtD
Morphine—Dermatitis—Triamcinolone—atopic dermatitis	7.31e-05	0.000244	CcSEcCtD
Morphine—Rash—Methylprednisolone—atopic dermatitis	7.3e-05	0.000244	CcSEcCtD
Morphine—Dermatitis—Methylprednisolone—atopic dermatitis	7.29e-05	0.000244	CcSEcCtD
Morphine—Urticaria—Prednisone—atopic dermatitis	7.28e-05	0.000244	CcSEcCtD
Morphine—Headache—Triamcinolone—atopic dermatitis	7.27e-05	0.000243	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	7.27e-05	0.000821	CbGpPWpGaD
Morphine—Headache—Methylprednisolone—atopic dermatitis	7.25e-05	0.000243	CcSEcCtD
Morphine—Body temperature increased—Prednisone—atopic dermatitis	7.25e-05	0.000242	CcSEcCtD
Morphine—Abdominal pain—Prednisone—atopic dermatitis	7.25e-05	0.000242	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	7.24e-05	0.000818	CbGpPWpGaD
Morphine—Diarrhoea—Betamethasone—atopic dermatitis	7.2e-05	0.000241	CcSEcCtD
Morphine—Diarrhoea—Dexamethasone—atopic dermatitis	7.2e-05	0.000241	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	7.16e-05	0.000809	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	7.14e-05	0.000806	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	7.1e-05	0.000802	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	7.1e-05	0.000802	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	7.06e-05	0.000797	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	7e-05	0.000791	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	6.99e-05	0.00079	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	6.98e-05	0.000789	CbGpPWpGaD
Morphine—Dizziness—Betamethasone—atopic dermatitis	6.96e-05	0.000233	CcSEcCtD
Morphine—Dizziness—Dexamethasone—atopic dermatitis	6.96e-05	0.000233	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	6.96e-05	0.000786	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PPARA—atopic dermatitis	6.92e-05	0.000782	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GLB1—atopic dermatitis	6.9e-05	0.00078	CbGpPWpGaD
Morphine—Nausea—Triamcinolone—atopic dermatitis	6.89e-05	0.00023	CcSEcCtD
Morphine—Nausea—Methylprednisolone—atopic dermatitis	6.88e-05	0.00023	CcSEcCtD
Morphine—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	6.85e-05	0.000774	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	6.85e-05	0.000774	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.81e-05	0.000769	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	6.77e-05	0.000765	CbGpPWpGaD
Morphine—Hypersensitivity—Prednisone—atopic dermatitis	6.76e-05	0.000226	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.75e-05	0.000762	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	6.75e-05	0.000762	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.72e-05	0.000759	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCL5—atopic dermatitis	6.7e-05	0.000757	CbGpPWpGaD
Morphine—Vomiting—Dexamethasone—atopic dermatitis	6.69e-05	0.000224	CcSEcCtD
Morphine—Vomiting—Betamethasone—atopic dermatitis	6.69e-05	0.000224	CcSEcCtD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.68e-05	0.000754	CbGpPWpGaD
Morphine—Rash—Dexamethasone—atopic dermatitis	6.64e-05	0.000222	CcSEcCtD
Morphine—Rash—Betamethasone—atopic dermatitis	6.64e-05	0.000222	CcSEcCtD
Morphine—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	6.64e-05	0.00075	CbGpPWpGaD
Morphine—Dermatitis—Dexamethasone—atopic dermatitis	6.63e-05	0.000222	CcSEcCtD
Morphine—Dermatitis—Betamethasone—atopic dermatitis	6.63e-05	0.000222	CcSEcCtD
Morphine—UGT1A1—Metabolism—ADSL—atopic dermatitis	6.62e-05	0.000747	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	6.6e-05	0.000745	CbGpPWpGaD
Morphine—Headache—Betamethasone—atopic dermatitis	6.6e-05	0.000221	CcSEcCtD
Morphine—Headache—Dexamethasone—atopic dermatitis	6.6e-05	0.000221	CcSEcCtD
Morphine—Asthenia—Prednisone—atopic dermatitis	6.58e-05	0.00022	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—IL2—atopic dermatitis	6.5e-05	0.000735	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	6.5e-05	0.000734	CbGpPWpGaD
Morphine—Pruritus—Prednisone—atopic dermatitis	6.49e-05	0.000217	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	6.38e-05	0.000721	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	6.37e-05	0.00072	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	6.3e-05	0.000712	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.29e-05	0.000711	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	6.28e-05	0.000709	CbGpPWpGaD
Morphine—Diarrhoea—Prednisone—atopic dermatitis	6.27e-05	0.00021	CcSEcCtD
Morphine—Nausea—Betamethasone—atopic dermatitis	6.25e-05	0.000209	CcSEcCtD
Morphine—Nausea—Dexamethasone—atopic dermatitis	6.25e-05	0.000209	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	6.22e-05	0.000703	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	6.22e-05	0.000703	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NGF—atopic dermatitis	6.21e-05	0.000701	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.2e-05	0.0007	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCL8—atopic dermatitis	6.18e-05	0.000698	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	6.1e-05	0.000689	CbGpPWpGaD
Morphine—Dizziness—Prednisone—atopic dermatitis	6.06e-05	0.000203	CcSEcCtD
Morphine—UGT2B15—Metabolism—PPARA—atopic dermatitis	6.05e-05	0.000684	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PPARA—atopic dermatitis	6.05e-05	0.000684	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCR5—atopic dermatitis	6.04e-05	0.000682	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.92e-05	0.000669	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	5.92e-05	0.000668	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL2—atopic dermatitis	5.91e-05	0.000667	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	5.9e-05	0.000667	CbGpPWpGaD
Morphine—Vomiting—Prednisone—atopic dermatitis	5.83e-05	0.000195	CcSEcCtD
Morphine—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	5.79e-05	0.000654	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	5.79e-05	0.000654	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	5.79e-05	0.000654	CbGpPWpGaD
Morphine—Rash—Prednisone—atopic dermatitis	5.78e-05	0.000193	CcSEcCtD
Morphine—Dermatitis—Prednisone—atopic dermatitis	5.78e-05	0.000193	CcSEcCtD
Morphine—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	5.77e-05	0.000652	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	5.77e-05	0.000652	CbGpPWpGaD
Morphine—Headache—Prednisone—atopic dermatitis	5.74e-05	0.000192	CcSEcCtD
Morphine—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	5.68e-05	0.000642	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	5.63e-05	0.000636	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	5.6e-05	0.000632	CbGpPWpGaD
Morphine—Nausea—Prednisone—atopic dermatitis	5.45e-05	0.000182	CcSEcCtD
Morphine—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.43e-05	0.000614	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	5.43e-05	0.000613	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	5.39e-05	0.000608	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	5.33e-05	0.000602	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	5.31e-05	0.000599	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	5.26e-05	0.000594	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	5.26e-05	0.000594	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	5.16e-05	0.000583	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	5.14e-05	0.000581	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NFKBIA—atopic dermatitis	5.12e-05	0.000578	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	5.06e-05	0.000572	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	5.06e-05	0.000572	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5e-05	0.000565	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	4.93e-05	0.000557	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	4.91e-05	0.000555	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	4.89e-05	0.000552	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.89e-05	0.000552	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	4.84e-05	0.000547	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	4.81e-05	0.000543	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	4.76e-05	0.000537	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	4.73e-05	0.000534	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	4.7e-05	0.000531	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	4.68e-05	0.000528	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	4.59e-05	0.000519	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.53e-05	0.000512	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	4.51e-05	0.000509	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.41e-05	0.000498	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	4.36e-05	0.000493	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	4.28e-05	0.000483	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	4.28e-05	0.000483	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	4.25e-05	0.00048	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	4.21e-05	0.000476	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	4.19e-05	0.000474	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NPS—atopic dermatitis	4.19e-05	0.000474	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	4.17e-05	0.000471	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	4.13e-05	0.000466	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	4.11e-05	0.000464	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	4.02e-05	0.000454	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	3.95e-05	0.000446	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL5—atopic dermatitis	3.9e-05	0.00044	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	3.83e-05	0.000432	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	3.81e-05	0.00043	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	3.68e-05	0.000415	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NPS—atopic dermatitis	3.68e-05	0.000415	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL8—atopic dermatitis	3.65e-05	0.000412	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GLB1—atopic dermatitis	3.63e-05	0.00041	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	3.61e-05	0.000407	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	3.59e-05	0.000405	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	3.56e-05	0.000402	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL2—atopic dermatitis	3.49e-05	0.000394	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	3.49e-05	0.000394	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ADSL—atopic dermatitis	3.48e-05	0.000394	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL6—atopic dermatitis	3.47e-05	0.000392	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL5—atopic dermatitis	3.42e-05	0.000386	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	3.32e-05	0.000375	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PPARA—atopic dermatitis	3.24e-05	0.000366	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	3.23e-05	0.000365	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MAPK8—atopic dermatitis	3.21e-05	0.000363	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GLB1—atopic dermatitis	3.17e-05	0.000358	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	3.11e-05	0.000351	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NPS—atopic dermatitis	3.11e-05	0.000351	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.07e-05	0.000346	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.05e-05	0.000344	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ADSL—atopic dermatitis	3.04e-05	0.000343	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.98e-05	0.000337	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	2.91e-05	0.000329	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.91e-05	0.000328	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL5—atopic dermatitis	2.89e-05	0.000326	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	2.86e-05	0.000323	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.86e-05	0.000323	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	2.78e-05	0.000314	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARA—atopic dermatitis	2.76e-05	0.000311	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NGF—atopic dermatitis	2.65e-05	0.000299	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.65e-05	0.000299	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	2.64e-05	0.000298	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	2.58e-05	0.000291	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.55e-05	0.000288	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	2.52e-05	0.000285	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	2.51e-05	0.000283	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.46e-05	0.000278	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	2.43e-05	0.000275	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.43e-05	0.000274	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NGF—atopic dermatitis	2.32e-05	0.000262	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	2.31e-05	0.000261	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	2.26e-05	0.000255	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARA—atopic dermatitis	2.24e-05	0.000253	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	2.21e-05	0.00025	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.19e-05	0.000248	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	2.19e-05	0.000247	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.15e-05	0.000243	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	2.12e-05	0.000239	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.06e-05	0.000232	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—atopic dermatitis	2.05e-05	0.000232	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NGF—atopic dermatitis	1.96e-05	0.000222	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.96e-05	0.000221	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.95e-05	0.00022	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.92e-05	0.000216	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	1.91e-05	0.000216	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.87e-05	0.000211	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	1.87e-05	0.000211	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.62e-05	0.000183	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.56e-05	0.000176	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—atopic dermatitis	1.49e-05	0.000168	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	1.48e-05	0.000167	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.37e-05	0.000155	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.37e-05	0.000154	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.31e-05	0.000148	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.3e-05	0.000147	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.2e-05	0.000136	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.18e-05	0.000133	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.15e-05	0.00013	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—atopic dermatitis	1.1e-05	0.000125	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	1.1e-05	0.000124	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARA—atopic dermatitis	1.03e-05	0.000116	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.02e-05	0.000115	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARA—atopic dermatitis	9.68e-06	0.000109	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—atopic dermatitis	8.75e-06	9.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—atopic dermatitis	7.68e-06	8.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—atopic dermatitis	6.49e-06	7.33e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.33e-06	7.15e-05	CbGpPWpGaD
